Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Cue Biopharma, Inc. (CUE) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/18/2022 SC 13G Slate Path Capital LP reports a 5.6% stake in Cue Biopharma, Inc.
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2022 SC 13G STATE STREET CORP reports a 5.2% stake in INITIAL FILING CUE BIOPHARMA INC
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2020 SC 13G BlackRock Inc. reports a 6% stake in CUE BIOPHARMA INC
02/12/2018 SC 13G APPEL PETER A reports a 7.6% stake in Cue Biopharma, Inc.
01/09/2018 SC 13G STROME MARK E reports a 5.7% stake in Cue Biopharma, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy